MedPath

HPV Message Testing and Social Media Campaign

Not Applicable
Completed
Conditions
Human Papilloma Virus
Vaccine
Interventions
Other: Social Media Message about HPV and HPV vaccine
Other: Social media message about risk of electronic cigarettes.
Registration Number
NCT03747302
Lead Sponsor
Dartmouth-Hitchcock Medical Center
Brief Summary

This project involves a social media campaign to increase parent's knowledge and acceptance of the HPV (human papillomavirus) vaccine. The current vaccine protects against nine types of HPV, including seven that are known to cause cancer. The Centers for Disease Control and Prevention (CDC) estimates that the current HPV vaccine could prevent 90% of cancer cases caused by HPV, including cases of cervical cancer, oropharyngeal (mouth and throat) cancer, anal cancer, and others. About 150 and 104 cases of HPV-associated cancers are diagnosed each year in New Hampshire and Vermont, respectively-many of which could be prevented through vaccination. Currently, only 49.8% of New Hampshire adolescents and 44.3% of Vermont adolescents were not up-to-date for HPV vaccination as of 2016. This social media campaign is testing a set of campaign messages with parents locally and nationally to see which messages are most effective in improving their knowledge and acceptance of the vaccine. A study survey link will monitor the number of people reached and will measure parental intention to get their children vaccinated against HPV.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
1043
Inclusion Criteria
  • parents of children 9-14 years old
Exclusion Criteria
  • non-parents

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
HPV MessagingSocial Media Message about HPV and HPV vaccineSubjects are randomized to receive one of five messages on one of the four themes about HPV vaccination.
Control MessageSocial media message about risk of electronic cigarettes.Subjects are randomized to receive one of five messages about electronic cigarettes.
Primary Outcome Measures
NameTimeMethod
Change in Attitudes About HPV VaccinePost test completed < 1 hour post messaging intervention

Change in Attitudes about HPV vaccine: Pre to post test comparison of summated 9 items measured on a 7-point scale of HPV vaccine attitudes. Scores range from a minimum of 9 to a maximum of 63. Higher scores indicated more positive attitudes toward HPV vaccination. Change was calculated from two time points, the later time point(\<1 hour post messaging intervention) minus value at baseline.

Secondary Outcome Measures
NameTimeMethod
Behavioral Intention to Vaccinate Their Child With HPV VaccineOre test immediately before viewing message and post- test immediately after viewing message. Approximately one hour.

A sub-group of parents of 9-14 year old children who had not been vaccinated were asked on pre- and post-test: How likely is it that she/he will receive the HPV vaccine in the next 12 months? Responses range form 1 (very likely) to 5 (not very likely).

HPV vaccination behavioral intent change scores were calculated by subtracting pre- and post- test values. It is a negative-value scale, in which smaller values indicate more positive attitude change after exposure to the viewed message.

Trial Locations

Locations (1)

Dartmouth-Hitchcock Medical Center

🇺🇸

Lebanon, New Hampshire, United States

© Copyright 2025. All Rights Reserved by MedPath